Inverness Medical Innovations, Inc. (NYSE: IMA) has entered a distribution agreement with Epocal Inc. for the distribution of its epoc Blood Analysis System for blood gas and electrolyte testing. The epoc (enterprise point of care) platform is a point of care analysis system which is used to provide wireless bedside blood gas and electrolyte measurement testing solutions. The epoc System utilizes disposable Smart-Cards to produce laboratory quality results in critical and acute care settings in just 30 seconds.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
About Inverness Medical Innovations
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
